Completed PHASE4 INTERVENTIONAL 2-arm NCT00699023

Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes (EZE)

Effects of Ezetimibe in Association With Statins on Postprandial Lipemia in Type 2 Diabetic Patients

Sponsor: Federico II University

Conditions Postprandial Lipemia Type 2 Diabetes

Interventions ezetimibe tablets placebo simvastatin tablets

Updated 5 times since 2017 Last updated: Nov 3, 2009 Started: Jun 30, 2008 Primary completion: Oct 31, 2009 Completion: Oct 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00699023, this PHASE4 trial focuses on Postprandial Lipemia and Type 2 Diabetes and remains completed. Sponsored by Federico II University, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Federico II University

Data source: Federico II University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Naples, Italy